Is Adverum Biotechnologies, Inc. (ADVM) a Buy, Sell, or Hold?
Adverum Biotechnologies, Inc.
NASDAQ:ADVM
$4.36 USD
$0 (0.0%)
- Volume
- 675.98K
- Average Volume
- 724.34K
- Market Capitalization
- $96.26M
- P/E Ratio
- -0.66
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $6.07
- Year Low
- $1.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.65
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Laurent Fischer |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | ADVM |
| CUSIP | 00773U207 |
| CIK | 0001501756 |
| Web | https://www.adverum.com |
| Phone | 650 656 9323 |
| Currency | USD |
| Employees | 155 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -1.60 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.65 |
| Quick Ratio | 0.65 |
| Cash Ratio | 0.58 |
Sales & Book Value
| Annual Sales | $1M |
| Price / Sales | 0.00 |
| Cash Flow | -4.69 |
| Price / Cash Flow | -0.87 |
| Price / Book | -1.84 |
Price Target and Rating
| Average Stock Price Forecast | $5.00 |
| High Stock Price Forecast | $28.00 |
| Low Stock Price Forecast | $2.00 |
| Forecast Upside/Downside | -12.80% |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 16 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-6.62 |
| Trailing P/E Ratio | -0.66 |
| PEG Ratio | 0.01 |
| P/E Growth | 0.01 |
| Net Income | $-130.93M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 872.77% |
| Return on Assets | -198.70% |
Financials Score
| AltmanZ Score | -32.54 |
| Piotroski Score | 1.00 |
| Working Capital | -15.84M |
| Total Assets | 72.4M |
| Ebit | -204.39M |
| Market Cap | 96.26M |
| Total Liabilities | 128.05M |
Poll Results
About Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Stock
Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various eye-related conditions and uncommon illnesses. Its flagship experimental gene therapy, ADVM-022, is a potential therapy administered through a single injection into the vitreous humor of the eye. This treatment is being developed for individuals afflicted with persistent retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies maintains licensing and collaborative partnerships with institutions such as the University of California and Cornell University, as well as companies like GenSight, Lexeo, and Virovek. Established in 2006, the ... organization was initially named Avalanche Biotechnologies, Inc. before rebranding to Adverum Biotechnologies, Inc. in May 2016. Its headquarters are situated in Redwood City, California.
Frequently Asked Questions
-
What is the current Adverum Biotechnologies, Inc. (ADVM) stock price?
-
Adverum Biotechnologies, Inc.(NASDAQ:ADVM) stock price is $4.36 in the last trading session. During the trading session, ADVM stock reached the peak price of $6.07 while $1.78 was the lowest point it dropped to. The percentage change in ADVM stock occurred in the recent session was 0.0% while the dollar amount for the price change in ADVM stock was $0.
-
ADVM's industry and sector of operation?
-
The NASDAQ listed ADVM is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ADVM?
-
Kishor Peter Soparkar | Chief Operating Officer
Linda Rubinstein | Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Rabia Gurses Ozden | Chief Medical Officer
R. Andrew Ramelmeier | Chief Technology Officer
Aneta Ferguson | General Counsel -
How many employees does ADVM have?
-
Number of ADVM employees currently stands at 155. ADVM operates from 800 Saginaw Drive, Redwood City, CA 94063, US.
-
Link for ADVM official website?
-
Official Website of ADVM is: https://www.adverum.com
-
How do I contact ADVM?
-
ADVM could be contacted at phone #650 656 9323 and can also be accessed through its website. ADVM operates from 800 Saginaw Drive, Redwood City, CA 94063, US.
-
How many shares of ADVM are traded daily?
-
The average number of ADVM shares traded daily for last 3 months was 724.34K.
-
What is the market cap of ADVM currently?
-
The market value of ADVM currently stands at $96.26M with its latest stock price at $4.36